Annals of Neurology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Childhood Amyotrophic Lateral Sclerosis Caused by Excess Sphingolipid Synthesis
2021
-
Youth with Epilepsy Identify their Quality of Life Trajectories and Predictors: A 28-month Longitudinal National Study
2016
-
Cerebral Microbleeds as Predictors of Mortality and Morbidity: The Framingham Heart Study
2015
-
Efficacy of Sublingual Apomorphine (APL-130277) for the Treatment of "Off" Episodes in Patients with Parkinson's Disease
2015
-
Pharmacokinetic-Pharmacodynamic Effects of Sublingual Apomorphine (APL-130277) for the Acute Management of OFF Episodes in Parkinson's Disease Patients
2015
-
Pharmacokinetics, Safety and Tolerability of Sub-Lingually Administered Apomorphine (APL-130277) Compared to Subcutaneous Apomorphine in Healthy Volunteers
2015
-
Quality of Life in Childhood Epilepsy: a comparison with typical children and children with cerebral palsy
2015
-
Safety of Sublingual Apomorphine (APL-130277) for the Treatment of OFF Episodes in Patients with Parkinson's Disease
2015
-
Quality of Life among Children with Epilepsy from their Point of View
2014
-
Comparative Efficacy of Triptans for the Abortive Treatment of Migraine: A Multiple Treatment Comparison Meta-Analysis (MTC)
2012
-
Metabolic Abnormalities in the Caudate in Patients with Mitochondrial Disorders Measured Using Proton Magnetic Resonance Spectroscopy
2012
-
Caffeine and nicotine independently protect against haloperidol-induced downregulation of midbrain dopamine neurons
2006
-
Cholinesterase inhibitors and Alzheimer's disease: A two-year study in the Sunnybrook dementia cohort
2006
-
Microglial activation may mediate the toxic effects of haloperidol on midbrain dopamine neurons
2006
-
Death following clinical neonatal seizures: Results from a population-based study with > 10 years follow-up
2005
-
Clinical challenges in pediatric ischemic stroke: Data on over 1000 children with stroke from the 1-800-NO-CLOTS consultation service
2004
-
Utility of theoretical models in outcome and quality of life research: Example from childhood epilepsy outcome research
2004
-
Neurological outcome in survivors of neonatal arterial ischemic stroke and cerebral sinovenous thrombosis: A prospective longitudinal study
2003
-
Rapid induction of proapoptotic proteins in nigral dopamine neurons by antipsychotic medication
2003
-
Recurrent stroke: the role of prothrombotic disorders
2003
-
Evidence that antipsychotic drugs and 3-nitroproprionic acid independently induce cell death in midbrain dopamine neurons by activation of the apoptosis cascade
2002
-
Heme oxygenase suppressor activity in Alzheimer plasma
2002
-
Postconcussion syndrome is accompanied by prolonged latencies of visual evoked responses
2002
-
Serotonin syndrome: A case series of 16 patients
2002
-
A novel validated self-reporting health-related quality-of-life measure for children with epilepsy
2001
-
Determinants and markers for reduced bone mineralization and body growth in children with long-term epilepsy
2001
-
Gender differences in epilepsy
2001
-
Hospital-based pediatric neurology services in Canada
2001
-
Compromised mitochondrial function exacerbates the Parkinson's disease-like changes induced by antipsychotic drugs
2000
-
Neurological disorders in catatonic patients admitted to psychiatry
2000
-
Peripheral nerve hyperexcitability associated with schwannoma and antibodies to voltage-gated potassium channels
2000
-
Can neuroleptic drugs cause Parkinson's disease?
1999
-
Myopathy with hexagonally cross‐linked tubular arrays: A new autosomal dominant or sporadic congenital myopathy
1999
-
Measuring quality of life in childhood epilepsy: Methods and preliminary findings
1998
-
Recommendations from the Canadian Consensus Conference on Dementia
1998
-
Six-year follow-up of autonomic (vagal) control of seizures
1997
-
A prospective clinical study of congenital heart disease in pediatric stroke
1996
-
DIURNAL-VARIATION IN ACUTE NEUROLEPTIC-INDUCED DYSTONIA
1995
-
POSITRON EMISSION TOMOGRAPHY SCAN STUDIES IN A PRIMATE MODEL OF STRIATAL DEGENERATION - IMPLICATIONS FOR THE MITOCHONDRIAL HYPOTHESIS OF HUNTINGTONS-DISEASE
1994
-
RELATIONSHIP BETWEEN PRIMARY DIAGNOSIS AND RESPONSIVENESS TO LORAZEPAM IN PATIENTS PRESENTING TO A PSYCHIATRY SERVICE WITH CATATONIA
1994
-
NEUROPEPTIDE ABNORMALITIES IN CEREBRAL-CORTEX OF OLIVOPONTOCEREBELLAR ATROPHY POSTMORTEM BRAIN
1992
-
VAGAL AND ESOPHAGEAL-EVOKED POTENTIALS IN NORMAL, EPILEPTIC, AND DIABETIC-PATIENTS
1992
-
REDUCED CONCENTRATIONS OF VASOPRESSIN IN THE SUBSTANTIA NIGRA PARS COMPACTA IN POSTMORTEM PARKINSONS-DISEASE BRAIN
1988
-
CEREBRAL GRANULOMATOUS-ANGIITIS CAUSING MULTIPLE ISCHEMIC CEREBROVASCULAR ACCIDENTS IN A CHILD WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME
1987
-
CORTICOTROPIN-RELEASING FACTOR AND SOMATOSTATIN IN ALZHEIMERS-DISEASE - COMPARATIVE CHANGES IN POSTMORTEM CEREBRAL-CORTEX
1987
-
COMPLICATIONS OF LONG-TERM ANTICOAGULATION
1986
-
NEUROPEPTIDE-Y IS INCREASED IN HUNTINGTONS-DISEASE
1986
-
VASOACTIVE-INTESTINAL-PEPTIDE IMMUNOREACTIVITY IN ALZHEIMER CEREBRAL-CORTEX
1986
-
SOMATOSTATIN-LIKE IMMUNOREACTIVITY IN ALZHEIMERS-DISEASE
1985
-
VASOPRESSIN IN POSTMORTEM ALZHEIMER BRAIN
1985
-
INAPPROPRIATE ANTI-DIURESIS AND THE DETERIORATING STROKE
1981
-
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple Sclerosis.
2024
-
Prevalence and Distribution of Intracranial Vessel Occlusion on Angiography and Its Association with Functional Outcome in Patients with Atrial Fibrillation Presenting with Ischemic Stroke..
96:1115-1123.
2024
-
Intensive Blood Pressure Reduction is Associated with Reduced Hematoma Growth in Fast Bleeding Intracerebral Hemorrhage.
95:129-136.
2024
-
Intracranial Aneurysmosis with Multilobular Aneurysms and Brain Microaneurysms.
93:637-639.
2023
-
A Causal Classification System for Intracerebral Hemorrhage Subtypes.
93:16-28.
2023
-
COVID‐19‐Associated Critical Illness Myopathy with Direct Viral Effects.
91:568-574.
2022
-
Genome‐Wide Association Study Identifies First Locus Associated with Susceptibility to Cerebral Venous Thrombosis.
90:777-788.
2021
-
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis.
90:477-489.
2021
-
Polygenic Risk Score for Alzheimer's Disease in Caribbean Hispanics.
90:366-376.
2021
-
Optic Disc Classification by Deep Learning versus Expert Neuro‐Ophthalmologists.
88:785-795.
2020
-
Ultra‐Early Blood Pressure Reduction Attenuates Hematoma Growth and Improves Outcome in Intracerebral Hemorrhage.
88:388-395.
2020
-
Standards for Detecting, Interpreting, and Reporting Noncontrast Computed Tomographic Markers of Intracerebral Hemorrhage Expansion.
86:480-492.
2019
-
Final Results of the RHAPSODY Trial: A Multi‐Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A‐APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke.
85:125-136.
2019
-
A recessive ataxia diagnosis algorithm for the next generation sequencing era.
82:892-899.
2017
-
Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions.
82:196-207.
2017
-
Early cerebral small vessel disease and brain volume, cognition, and gait.
77:251-261.
2015
-
Deferiprone in Friedreich ataxia: A 6‐Month randomized controlled trial.
76:509-521.
2014
-
Overlapping demyelinating syndromes and anti–N‐methyl‐D‐aspartate receptor encephalitis.
75:411-428.
2014
-
Diffusion‐Weighted imaging hyperintensities in intracerebral hemorrhage: Microinfarcts or microbleeds?.
73:795-796.
2013
-
Anticoagulants in pediatric cerebral sinovenous thrombosis: A safety and outcome study.
67:590-599.
2010
-
Digit‐specific aberrations in the primary somatosensory cortex in Writer's cramp.
66:146-154.
2009
-
Diffuse axonal injury in children: Clinical correlation with hemorrhagic lesions.
56:36-50.
2004
-
Rhabdomyolysis and paraneoplastic stiff-man syndrome with amphiphysin autoimmunity..
55:286-290.
2004
-
Clasmatodendrosis correlating with periventricular hyperintensity in mixed dementia.
52:378-381.
2002
-
Hyperthermia induces age‐dependent changes in rat hippocampal excitability.
52:318-326.
2002
-
Reply.
52:126-127.
2002
-
Late‐onset metachromatic leukodystrophy clinically presenting as isolated peripheral neuropathy: Compound heterozygosity for the IVS2+1G→a mutation and a newly identified missense mutation (Thr408Ile) in a Spanish family.
50:108-112.
2001
-
Late‐onset metachromatic leukodystrophy clinically presenting as isolated peripheral neuropathy: Compound heterozygosity for the IVS2+1G→a mutation and a newly identified missense mutation (Thr408Ile) in a Spanish family.
50:108-112.
2001
-
Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders.
49:561-574.
2001
-
A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin.
42:857-865.
1997
-
Cortical peptide changes in Huntington's disease may be independent of striatal degeneration.
41:540-547.
1997
-
Impaired visual word processing in dyslexia revealed with magnetoencephalography.
40:157-162.
1996
-
Metachromatic leukodystrophy: Multiple nonfunctional and pseudodeficiency alleles in a pedigree: Problems with diagnosis and counseling.
34:212-218.
1993
-
The cortical lesion of Huntington's disease: Further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N‐methyl‐D‐aspartate lesions of rat cortex.
32:526-534.
1992
-
Paramyotonia congenita and hyperkalemic periodic paralysis are linked to the adult muscle sodium channel gene.
30:810-816.
1991
-
Complications of long‐term anticoagulation.
23:570-574.
1988
-
Somatostatin and neuropeptide Y concentrations in pathologically graded cases of huntington's disease.
23:562-569.
1988
-
Vasopressin in Alzheimer's disease: A study of postmortem brain concentrations.
20:665-670.
1986
-
A postmortem study of amino acid neurotransmitters in Alzheimer's disease.
20:616-621.
1986
-
Widespread reduction of somatostatin‐like immunoreactivity in the cerebral cortex in Alzheimer's disease.
20:489-495.
1986
-
Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease.
20:282-288.
1986
-
Reply.
19:611-612.
1986
-
Postoperative contrast enhancement in patients with brain tumor.
17:570-572.
1985
-
The origin of spontaneous electrical activity at the end‐plate zone.
10:557-560.
1981
-
Physiological observations in the median nerve during carpal tunnel surgery.
10:227-229.
1981
-
Cubital tunnel syndrome and ulnar neuropathy.
7:289-290.
1980
-
Chronic progressive myelopathy: Investigation with CSF electrophoresis, evoked potentials, and CT scan.
6:419-424.
1979
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)